Acino completes acquisition of M8 Pharmaceuticals significantly expanding presence and capabilities in Latin America
This acquisition provides Acino with access to the two largest pharmaceutical markets in Latin America, significantly expanding its geographic footprint and strengthening its position in the region.
- This acquisition provides Acino with access to the two largest pharmaceutical markets in Latin America, significantly expanding its geographic footprint and strengthening its position in the region.
- Integration of the M8 portfolio, pipeline, and operations with Acino is underway while both businesses continue to focus on their day-to-day operations.
- Andrew Bird, Interim CEO at Acino commented: “I am delighted to complete this transformational deal for Acino.
- I extend a warm welcome to nearly 300 new colleagues at M8 who have now joined the Acino family.”
Joel Barlan, CEO at M8 commented: “Today marks an exciting new chapter for M8 and Acino.